Prevnar

Prevnar®

Pediatrics A proprietary 7-valent conjugate vaccine for routine immunization against invasive pneumococcal disease in infants

Prevnar

(prĕv′năr)
Pneumococcal seven-valent conjugate vaccine
Mentioned in ?
References in periodicals archive ?
Global Prevnar 13/Prevenar 13 revenues declined 1% operationally in Q3.
If you've never received either vaccine, Prevnar 13 should be given first, followed a year later by Pneumovax.
If you are interested in providing a proposal for the above Prevnar Vaccine, you must contact the appropriately designated Campus contact in this advertisement within 15 business days of this Advertisement Notice
M2 EQUITYBITES-July 13, 2016-Pfizer receives FDA approval for Prevnar 13 expanded age indication against S.
Prevnar was FDA-approved for use in children in 2000 in the United States, and is now approved in more than four dozen countries.
Depending on the age of the patient, a second Prevnar 13 may be needed prior to receiving the Pneumovax 23.
the world's second-largest drug company in terms of revenue, makes drugs including the pain and arthritis treatment Celebrex, Prevnar pneumococcal vaccines, and fibromyalgia treatment Lyrica.
31 billion after recent approval of Prevnar 13, which blocks more strains of the bacteria.
The other is pneumococcal conjugate vaccine, PCV13 (brand name Prevnar 13), which is routinely given to infants and toddlers, but was approved by the FDA in 2011 for use in adults 50 and older.
She used the example of Prevnar 13, manufactured exclusively by Pfizer, which prevents ear infections, pneumonia and other diseases in children.
The company's top two sellers are now Lyrica, which treats nerve and muscle pain, and the Prevnar line of vaccines.
Summary: Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.